VivoSeq
Other

Painful Bladder Syndrome

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Painful Bladder Syndrome is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

3

clinical trials

Completed2 · 67%
Unknown status1 · 33%

Clinical Trials

Trial Activity

Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome
Completed·—·Phase 3·NCT06209008·30 enrolled
Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)
Completed·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 3·NCT00124306·271 enrolled
Botulinum A Toxin in the Treatment of Patients With Painful Bladder Syndrome
Unknown status·UUniversity Of Perugia·Phase 4·NCT01157507·30 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)